Skip to main content
Toggle navigation
Login
Search
Home
Icon Legend
This session is not in your Favorites.
This session is in your Favorites. Click again to remove it.
Presentation Icons
ACG Award Winner
ACG Newsworthy Abstract
Registration Required
No CME
On-Demand Video
Livestream
Favorite
Aisha Vadhariya
Eli Lilly and Company
Poster(s):
P3177 - Mirikizumab Improves Quality of Life in Patients With Crohn’s Disease Up to 2 Years of Treatment: Results From the VIVID-2 Study
Monday, October 27, 2025
10:30 AM - 4:00 PM
MT
P3178 - Patient-Level Dynamics of Clinical Response to Mirikizumab and Its Impact on Quality of Life: Analysis from the Vivid-1 Trial in Crohn’s Disease
Monday, October 27, 2025
10:30 AM - 4:00 PM
MT